Outcomes of endovascular management for patients with TASC IID superfacial femoral artery occlusive disease

Abstract

Background: Peripheral lower limb ischemia is a condition that is prevalent worldwide and that is likely to increase with age. The increased prevalence of diabetes mellitus and hypertension in the population is considered to an important risk factor for the spread of peripheral arterial disease. Aim of the Work: This is a prospective study to assess the role of endovascular management for surgical high risk patients with TASC II D superfacial femoral artery occlusive diseases. Patients and Methods: This prospective analytic study was conducted on twenty patients with TASC-II D superficial femoral artery lesions at El maadi and Kobry El Kobba military hospitals. Results: Technical success reported in 18/20 cases (90%), 2 cases failed (1 received bypass, 1 underwent major amputation).The Primary patency within 2 years is 65%, Primary assisted patency is 70 % and Secondary patency is 60%. Limb salvage (primary end point) reported in 95%. Amputation free survival reported in 95%. Conclusion: An endovascular intervention for TASC-II D lesions can be performed safely with acceptable patency and limb salvage rates. This approach should be considered especially in patients with multiple comorbidities. Restenosis is not uncommon in these complex lengthy lesions that mandate close follow-up.